From the Muscular Dystrophy Association Insights in Research Investor Summit


  • Michael Rice, MS, MBA, SVP, BioConsulting, Head of Advanced Therapeutics and Rare Diseases, Lumanity


  • Chris Garabedian, Xontogeny and Portfolio Manager, PXV Fund
  • Beth Seidenberg, Westlake Village BioPartners
  • Sharon Hesterlee, PhD, Muscular Dystrophy Association (MDA)
  • Lea Hachigian, Longwood Fund
  • Inbal Michailovici, FutureRx
Panel: 2:05:07 – 3:09:45